Delivery Order SPE2DB22D3501-SPE2DB25FWE58
Award Date 6/26/25
Potential Completion Date 7/18/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,673.08 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 8, 2025. This contract award is a part of a larger Indefinite Delivery Contract (IDC) valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $33,409.40, is for the delivery of the specialty medication HEMLIBRA 150 MG/ML. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,136.76 firm-fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,615.66 firm fixed-price delivery order is for the supply of HEMLIBRA 60 MG/0.4 ML VIAL 0.4ML, a specialty medication, with a completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,673.08, is for the supply of 4567331942 HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is for the supply of HEMLIBRA 150 MG/ML VIALML to the Defense Logistics Agency (DLA), a defense agency. The $35,268.76 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025, with a completion date of August 6, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
- The Defense Logistics Agency awarded a $17,634.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 150 mg/mL vials on August 25, 2025. This non-set-aside contract is scheduled for completion by September 16, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. HEMLIBRA is a specialized hemophilia A therapeutic product, reflecting the pharmaceutical distributor's role in supplying critical medications to support military and federal healthcare...
- The Defense Logistics Agency awarded a $24,673.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 105 mg/0.7 ml vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HEMLIBRA is a specialty pharmaceutical product used in hemophilia treatment, reflecting the federal government's need for advanced therapeutic...
- The Defense Logistics Agency awarded a delivery order valued at $26,451.57 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 150 mg/ml vials. This firm fixed price contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 105 MG/0.7 ML vials, with a ceiling value of $6,168.26 under a firm fixed-price contract. The award was made on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside delivery order represents a specific pharmaceutical procurement request fulfilled through the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in...